Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Irish Group Proposes Huge Bioresearch Center

by Rick Mullin
July 26, 2010 | A version of this story appeared in Volume 88, Issue 30

A group led by Pharmadel, a Cork, Ireland-based health care company, wants to establish a $6 billion pharmaceutical research center in Tralee, Ireland, that it claims will create 4,800 jobs. Alan Dukes, the director of Pharmadel, is the former chairman of Anglo Irish Bank. The former head of Pfizer’s Irish business, Paddy Caffrey, is on Pharmadel’s board of directors. However, no other drug or biotech company is listed as a member of the proposed center. The center’s backers issued a two-sentence statement confirming that the group is negotiating with the government. Sources in the Irish pharmaceutical industry say the announcement took them by surprise.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.